Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131652) titled 'The efficacy and safety of hierarchical collateral artery embolization (TAE) and sequential hepatic artery infusion chemotherapy (HAIC) in the treatment of unresectable primary hepatocellular carcinoma: a prospective real-world study' on Sept. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Jiangjin Central Hospital of Chongqing
Condition:
Initial unresectable primary hepatocellular carcinoma
Intervention:
Convention TAE:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-10-10
Target Sample Size: Convention TAE:48;Multi-level collateral arte...